|
Erdafitinib Clinical Trials
2 actively recruiting trials across 1 location
Also known as: Balversa, JNJ 42756493, JNJ-42756493, JNJ42756493
Pipeline
Phase 2: 2
Top Sponsors
- The Netherlands Cancer Institute1
- National Cancer Institute (NCI)1
Indications
- Cancer2
- Recurrent WHO Grade 2 Glioma1
- Recurrent WHO Grade 4 Glioma1
- Recurrent WHO Grade 3 Glioma1
- Neoplasia1
Other1 trial
Aurora, Colorado1 trial
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
UCHealth University of Colorado Hospital
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.